A Recipe for Proteomics Diagnostic Test Development: The OVA1 Test, from Biomarker Discovery to FDA Clearance

被引：97

作者：

Fung, Eric T. ^{[1
]}

机构：

[1] Vermillion Inc, Fremont, CA 94538 USA

来源：

CLINICAL CHEMISTRY | 2010年 / 56卷 / 02期

关键词：

OVARIAN-CANCER;

D O I：

10.1373/clinchem.2009.140855

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：327 / 329

页数：3

共 4 条

[1]

*FDA, FDA CLEARS TEST OV C

[2] Who should operate on patients with ovarian cancer? An evidence-based review [J].

Giede, KC ;

Kieser, K ;

Dodge, J ;

Rosen, B .

GYNECOLOGIC ONCOLOGY, 2005, 99 (02) :447-461

[3] Strategies for discovering novel cancer biomarkers through utilization of emerging technologies [J].

Kulasingam, Vathany ;

Diamandis, Eleftherios P. .

NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (10) :588-599

[4] Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer [J].

Zhang, Z ;

Bast, RC ;

Yu, YH ;

Li, JN ;

Sokoll, LJ ;

Rai, AJ ;

Rosenzweig, JM ;

Cameron, B ;

Wang, YY ;

Meng, XY ;

Berchuck, A ;

van Haaften-Day, C ;

Hacker, NF ;

de Bruijn, HWA ;

van der Zee, AGJ ;

Jacobs, IJ ;

Fung, ET ;

Chan, DW .

CANCER RESEARCH, 2004, 64 (16) :5882-5890

← 1 →